Orano Med, a pioneer in radioligand therapies in oncology, inaugurated the expansion of its R&D Center located in Plano, Texas (USA).

Orano Med Inaugurates Expansion of its U.S ... to develop lead-212-based radioligand therapies by giving our teams the resources they need to advance a growing pipeline of drug candidates ...

Orano Med, a subsidiary of the ... The expansion includes around 5,000 ft² of new laboratory space, enabling the advancement of a growing pipeline and doubling the Good Manufacturing Practice ...

Approximately 75,000 new residents are expected to move to Knox County by 2040. Who are they, and where are they coming from?

A high-level overview of Molecular Partners AG (MOLN) stock. View (MOLN) real-time stock price, chart, news, analysis, analyst reviews and more.

Molecular Partners AG and Orano Med have announced the development of MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) for ovarian cancer treatment, which shows promising tumor ...

Sanofi's investment raises the value of Orano Med to €1.9 billion and gives it a 16% stake in the company, which focuses on the development of radiotherapies based on lead-212, an isotope that ...

Orano USA and more than 100 federal, state, business, and regional leaders recently marked a major milestone for Project IKE, the company's development of America's new multibillion-dollar uranium ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find ...

The Orano-Bond has a maturity date of 3/12/2031 and offers a coupon of 4.0000%. The payment of the coupon will take place 1,0 times per Year on the 12.03.. At the current price of 103.045 EUR this ...

2:18 Legault says he’s ‘willing to listen’ to pipeline proposals at premiers’ meeting At a meeting of Canada’s premiers in Saskatchewan, François Legault said he’s willing to listen ...